| Title： | Evaluation and treatment of gastrointestinal complications following congenital esophageal atresia surgery |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Surgeons and clinical physicians |
| Evidence classification method： | This consensus has been strictly formulated in accordance with the "Basic Concepts and Formulation Norms of Clinical Guidelines and Expert Consensus"[4]. The "Grading of Recommendations, Assessment, Development, and Evaluation (GRADE)" system was used to assess the quality of evidence and the strength of recommendations. The quality of evidence sources is classified into four categories: 1. High (A) - Future research is unlikely to change the credibility of the current efficacy evaluation results. 2. Moderate (B) - Future research may have a significant impact on the current efficacy evaluation and may change the evaluation results. 3. Low (C) - Future research is very likely to have a significant impact on the current efficacy evaluation, with a high possibility of changing the evaluation results. 4. Very low (D) - Any evaluation of efficacy is very uncertain. The strength of the recommendations is divided into: 1. Strong recommendation - Clearly shows that the benefits of the intervention outweigh the harms or vice versa. 2. Weak recommendation - The benefits and harms are uncertain, or the evidence shows that the benefits and harms are roughly equal regardless of quality. All recommendations were agreed upon by at least 75% of the expert consensus group members, ultimately forming the following consensus. |
| Development unit： | Beijing Children's Hospital, Capital Medical University |
| Registration time: | 2024-07-31 |
| Registration number： | PREPARE-2024CN094 |
| Purpose of the guideline: | This consensus aims to summarize relevant expert opinions on gastroesophageal reflux, esophageal motility disorders, eosinophilic esophagitis, and the management of gastroesophageal diseases in adolescents and adults. The objective is to guide the treatment process, further standardize the postoperative management of patients with congenital esophageal atresia, and improve their postoperative quality of life. |
